VZV: Immunobiology and host response

Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis

Volumn , Issue , 2007, Pages 700-712

  Arvin, Ann ^a   Abendroth, Allison ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84859429778     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545313.040     Document Type: Chapter

References (87)

1. Abendroth, A., Slobedman, B., Eunice, L., Mellins, E., Wallace, M., and Arvin, A. M. (2000). Modulation of MHC class II protein expression by varicella zoster virus. J. Virol., 74, 1900-1907.
2. Abendroth, A., Lin, I., Slobedman, B., Ploegh, H., and Arvin, A. M. (2001a). Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. J. Virol.,75, 4878-4888.
3. Abendroth, A., Morrow, G., Cunningham, A. L. and Slobedman, B. (2001b). Varicella-zoster virus infection of human dendritic cells and transmission to T cells: Implications for virus dis-semination in the host. J. Virol., 75, 6183-6192.
4. Ahn, K., Meyer, T. H., Uebel, S. et al. (1996). Molecular mechanism and species specicity of TAP inhibition by herpes simplex virus ICP47. EMBO. J., 15, 3247-3255.
5. Arvin, A. M. (1999). Varicella-zoster virus. In Persistent Viral Infec-tions of Humans. eds. Ahmed, R. and Chen, I. S. Y., pp. 183-208. Chicheaces, UK: John Wiley.
6. Arvin, A. M. (2001). Varicella-zoster virus. In Fields' Virology, ed. Howley, P. and Knipe, D. M. 4th edn, pp. 2731-2768. Philadelphia: Lippincott-Williams & Wilkins.
7. Arvin, A. M., Koropchak, C. M., Williams, B. R., Grumet, F. C., and Foung, S. K. (1986a). Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J. Infect. Dis., 154, 422-429.
8. Arvin, A. M., Kinney-Thomas, E., Shriver, K. et al. (1986b). Immunity to varicella-zoster viral glycoproteins, gp I (90/58) and gp III (gp 118) and to a nonglycosylated protein, p170. J. Immunol., 137, 1346.
9. Arvin, A. M., Sharp, M., Smith, S. etal.(1991). Equivalentrecognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype. J. Immunol., 146, 257-264.
10. Arvin, A. M., Moffat, J. F., and Redman, R. (1996). Varicella-zoster virus: Aspects of pathogenesis and host response to natu-ral infection and varicella vaccine. Adv. Virus Res., 46, 263-309.
11. Asada, H., Klaus-Kovtun, V., Golding, H., Katz, S. I. and Blauvelt., A. (1999). Human herpesvirus-6 infects dendritic cells and sup-presses human immunodeciency virus type-1 replication in coinfected cultures. J. Virol., 73, 4019-4028.
12. Auwaerter, P. G., Kaneshima, H., McCune, J. M., Wiegand, G. and Grifn, D. E. (1996). Measles virus infection of thymic epithe-lium in the SCID-hu mouse leads to thymocyte apoptosis. J. Virol., 70, 3734-3740.
13. Banchereau, J. and Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature, 392, 245-252.
14. Banchereau, J., Briere, F., Caux, C. et al. (2000). Immunobiology of dendritic cells. Annu. Rev. Immunol., 18, 767-811.
15. Bender, A., Albert, M., Reddy, A. et al. (1998). The distinctive features of inuenza virus infection of dendritic cells. Immunobiology, 198, 552-567.
16. Bergen, R. E., Sharp, M., Sanchez, A., Judd, A. K., and Arvin, A. M. (1991). Human T cells recognize multiple epitopes of an imme-diate early/tegument protein (IE62) and glycoprotein I of vari-cella zoster virus. Viral Immunol., 4, 151-166.
17. Bhardwaj, N. (1997). Interactions of Viruses with dendritic cells: A double-edged sword. J. Exp. Med., 186, 795-799.
18. Bhardwaj, N., Bender, A., Gonzalez, N. et al. (1994). Inuenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J. Clin. Invest., 94, 797-807.
19. Blauvelt, A., Asada, H., Saville, W. M. et al. (1997). Productive infec-tion of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways. J. Clin. Invest., 100, 2043-2053.
20. Cella, M., Engering, A., Pinet, V., Pieters, J. and Lanzavecchia, A. (1997). Inammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature, 388, 782-787.
21. Cohen, J. I. (1998). Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocom-patibility complex antigens. J. Infect. Dis., 177, 1390-1393.
22. Cohen, O. J. and Fauci, A. S. (2001). Pathogenesis and medical aspects of HIV-1 infection In Fields’ Virology 4th edn Knipe, D. M. and Howley, P. M. eds, pp. 2043-2094.
23. Cooper, E. C., Vujcic, L. K., and Quinnan, G. V. Jr. 1988. Varicella-zoster virus-specic HLA-restricted cytotoxicity of normal immune adult lymphocytes after in vitro stimulation. J. Infect. Dis., 158,780-788.
24. Devlin, M. E., Gilden, D. H., Mahalingam, R. et al. (1992). Peripheral blood mononuclear cells of the elderly contain varicella-zoster virus DNA. J. Infect. Dis., 165, 619.
25. Diaz, P. S., Smith, S., Hunter, E., and Arvin, A. M. (1989). T lympho-cyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine. J. Immun., 142, 636-641.
26. Esolen, L. M., Park, S. W., Hardwick, J. M., and Grifn. D. E. (1995). Apoptosis as a cause of death in measles virus-infected cells. J. Virol., 69, 3955-3958.
27. Frey, C. R., Sharp, M. A., Min, A. S., Schmid, D. S., Loparev, V., and Arvin, A. M. (2003). Identication of CD8+ T cell epitopes in the immediate early protein 62 of varicella-zoster virus and evalu-ation of CD8+ T cell responder frequencies to the immediate early protein 62 using IE62 peptides after varicella vaccination. J. Infect. Dis., 188, 40-52.
28. Fruh, K., Ahn, K., Djaballah, H. et al. (1995). A viral inhibitor of peptide transporters for antigen presentation. Nature, 375, 415-418.
29. Fruh, K., Gruhler, A., Krishna, R., and Schoenhals, G. (1999). A com-parison of viral immune escape strategies targeting the MHC class I assembly pathway. Immunol. Revs., 168, 157-166.
30. Fugier-Vivier, I., Servat-Delprat, C., Rivailler, P., Rissoan, M. C., Liu, Y. J. and Rabourdin-Combr, C. (1997). Measles virus sup-presses cell mediated immunity by interfering with the sur-vival and function of dendritic and T-cells. J. Exp. Med., 186, 813-823.
31. Galocha, B., Hill, A., Barnett, B. et al. (1997). The active site of ICP47, aherpessimplexvirus-encodedinhibitorofmajorhistocomat-ibility complex (MHC)-encoded peptide transport associated with antigen processing (TAP), maps to the NH2-terminal 35 residues. J. Exp. Med., 185, 1565-1572.
32. Gershon, A. A., Steinberg, S. P., and Gelb, L. (1984). Clinical reinfection with varicella-zoster virus. J. Infect. Dis., 149, 137.
33. Grose, C. (1981). Variation on a theme by Fenner: The pathogenesis of chicken pox. Pediatrics, 68, 735-737.
34. Grosjean, I., Caux, C., Bella, C. et al. (1997). Measles virus infects human dendritic cells and blocks their allostimulatory prop-erties for CD4+ T-cells. J. Exp. Med., 186, 801-812.
35. Hata, A., Asanuma, H., Rinki, M. et al. (2002). Protection of hematopoietic cell transplant reciplents from herpes zoster by an inactivated varicella vaccine. N. Engl. J. Med., 347, 26-34.
36. Hayward, A. R., Pontesilli, O., Herberger, M., Laszlo, M., and Levin. M. (1986). Specic lysis of varicella zoster virus-infected B lym-phoblasts by human T cells. J. Virol., 58, 179-184.
37. Hayward, A., Giller, R., and Levin, M. (1989). Phenotype, cyto-toxic, and helper functions of T cells from varicella zoster virus stimulated cultures of human lymphocytes. Viral Immun., 2, 175-184.
38. Heise, M. T., Connick, M., and Virgin, H. W. T. (1998). Murine cytomegalovirus inhibits interferon gamma-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes. J. Exp. Med., 187, 1037-1046.
39. Hertel, L., Lacaille, V. G., Strobl, H., Mellins, E. D., and Mocarski, E. S. (2003). Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J. Virol. 77(13), 7563-7574.
40. Hickling, J. K., Borysiewicz, L. K., and Sissons, J. G. (1987). Varicella-zoster virus-specic cytotoxic T lymphocytes (Tc): Detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood. J. Virol., 61, 3463-3469.
41. Hill, A., Jugovic, P., York, I. et al. (1995). Herpes simplex virus turns off the TAP to evade host immunity. Nature., 375, 411-415.
42. Ihara, T., Kato, T., Torigoe, S. et al. (1991). Antibody response deter-mined with antibody-dependent cell-mediated cytotoxicity (ADCC), neutralizing antibody, and varicella skin test in chil-dren with natural varicella and after varicella immunization. Acta Paediatr. Jap. 33, 43.
43. Jenkins, D. E., Redman, R. L., Lam, E. M., Liu, C., Lin, I., and Arvin, A. M. (1998). Interleukin (IL)-10, IL-12, and interferon-gamma production in primary and memory immune responses to varicella-zoster virus. J. Infect. Dis., 178, 940-948.
44. Jenkins, D. E., Yasukawa, L. L., Bergen, R., Benike, C., Engleman, E. G., and Arvin. A. M. (1999). Comparison of primary sensitiza-tion of naive human T cells to varicella zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination. J. Immunol., 162, 550-567.
45. Jones, J. O. and Arvin A. M. (2006). Inhibition of the NF-kB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo. J. Virol., 80, 5113-5124.
46. Jones, T. and Sun, L. (1997). Human cytomegalovirus US2 desta-bilizes major histocompatibility complex class I heavy chains. J. Virol., 71, 2970-2979.
47. Jones, T. R., Wiertz, E. J., Sun, L., Fish, K. N., Nelson, J. A., and Ploegh, H. L. (1996). Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl Acad. Sci. USA, 93, 11327-11330.
48. Jones, C. A., Fernandez, M., Herc, K. et al. (2003). Herpes simplex virus type 2 induces rapid cell death and functional impair-ment of murine dendritic cells in vitro. J. Virol., 77(20), 11139-11149.
49. Kakimoto, M., Hasegawa, A., Fujita, S., and Yasukawa, M. (2002). Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection. J. Virol., 76, 10338-10345.
50. Kinchington, P. R. and Cohen, J. I. (2000). Varicella zoster virus pro-teins In Varicella Zoster Virus. Virology and Clinical Manage-ment. Arvin, A. M. and Gershon, A. A., eds., pp. 74-104. Cam-bridge, UK: Cambridge University Press.
51. Klagge, I. M. and Schneider-Schaulies, S. (1999). Virus interactions with dendritic cells. J. Gen. Virol., 80, 823-833.
52. Kleijnen, M., Huppa, J., Lucin, P. et al. (1997). A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J., 16, 685-694.
53. Ku, C. C., Padilla, J., Grose, C., Butcher, E. C., and Arvin, A. M. (2002). Tropism of varicella-zoster virus for human tonsillar CD4+ T lymphocytes that express activation, memory and skin homing markers. J. Virol., 76, 11425-11433.
54. Kruse, M., Rosorius, O., Kratzer, F. et al. (2000). Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J. Virol., 74, 7127-7136.
55. Ku, C.-C., Zerboni, L., Besser, J., Ito, H., and Arvin, A. M. (2004) (Transport) of varicella-zoster virus to skin by infected CD4 T cells and modulation of skin infection by innate immunity in vivo. J. Exp. Med., 200, 917-925.
56. Lechmann, M., Berchtold, S., Hauber, J., and Steinkasserer, A. (2002). CD83 on dendritic cells: More than just a marker for maturation. Trends Immunol., 23, 273-275.
57. Macatonia, S. E., Gompels, M., Pinching, A. J., Patterson, S., and Knight, S. C., (1992). Antigen-presentation by macrophages but not by dendritic cells in human immunodeciency virus (HIV) infection. Immunology, 75, 576-581.
58. Machold, R., Wiertz, E., Jones, T., and Ploegh, H. (1997). The HCMV gene products US11 and US2 differ in their abil-ity to attack allelic forms of murine major histocompatibil-ity complex (MHC) class I heavy chains. J. Exp. Med., 185, 363-366.
59. Marland, G., Bakker, B., Adema, G. J., and Figdor, C. G. (1996). Dendritic cells in immune response induction. Stem Cells, 14, 501.
60. Merigan, T. C., Rand, K. H., Pollard, R. B. et al. (1978). Human leuko-cyte interferon for the treatment of herpes zoster in patients with cancer. N. Engl. J. Med., 298, 981.
61. Miller, D. M., Rahill, B. M., Boss, J. M. et al. (1998). Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med., 187, 675-683.
62. Moffat, J. F., Stein, M. D., Kaneshima, H., and Arvin, A. M. (1995). Tropism of varicella zoster virus for human CD4+ and CD8+ T-lymphocytes and epidermal cells in SCID-hu mice. J. Virol., 69, 5236-5242.
63. Morrow, G., Slobedman, B., Cunningham, A. L., and Abendroth, A. (2003). Varicella zoster virus productively infects mature den-dritic cells and alters their immune function. J. Virol., 77(8), 4950-4959.
64. Oxman, M. N., Levin, M. J., Johnson, G. R. et al. (2005). A vaccine to prevent herpes zoster and postherpetic neuralgia in order adults. N. Eng. J. Med., 352(22), 2271-2284.
65. Raftery, M. J., Schwab, M., Eibert, S. M., Samstag, Y., Walczak, H., and Schonrich, G. (2001). Targeting the function of mature dendritic cells by human cytomegalovirus: A multilayered viral defense strategy. Immunity, 15, 997-1009.
66. Reusch, U., Muranyi, W., Lucin, P., Burgert, H., Hengel, H., and Koszinowski, U. (1999). A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J., 18, 1081-1091.
67. Riegler, S., Hebart, H., Einsele., Brossart, P., Jahn, G., and Sinzger, C. (2000). Monocyte derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J. Gen. Virol., 81, 393-399.
68. Salio, M., Cella, M., Suter, M., and Lanzavecchia, A. (1999). Inhibi-tion of dendritic cell maturation by herpes simplex virus. Eur. J. Immunol., 29, 3245-3253.
69. Schnorr, J. J., Xanthakos, S., Keikavoussi, P., Kampgen, E., ter Meulen, V., and Schneider-Schaulies, S. (1997). Induction of maturation of human blood dendritic cell precursors by measles virus in association with immunosuppression. Proc. Natl Acad. Sci. USA, 92, 5326-5331.
70. Sevilla, N., Kunz, S., Holz, A. et al. (2000). Immunosuppression and resultant viral persistence by specic viral targeting of den-dritic cells. J. Exp. Med., 192, 1249-1260.
71. Sharp, M., Terada, K., Wilson, A. et al. (1992). Kinetics and viral protein specicity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vac-cine. J. Infect. Dis., 165, 852-858.
72. Steinman, R. M. (1991). The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol., 9, 271-296.
73. Steinman, R. M. (1999). Dendritic cells. In Fundamental Immunol-ogy, 4th edn. Paul, W. E., ed., pp. 547-573. Philadelphia: Lip-pincott Raven Publishers.
74. Steinman, R. M., Pack, M., and Inaba, K. (1997). Dendritic cell devel-opment and maturation. Adv. Exp. Med. Biol., 417, 1.
75. Stevens, D. A., Ferrington, R. A., Jordan, G. W., et al. (1975) Cellular events in zoster vesicles: Relation to clin-ical course and immune parameters. J. Infect. Dis., 131, 509.
76. Tomazin, R., Hill, A. B., Jugovic, P. et al. (1996). Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J., 15, 3256-3266.
77. Wallace, M. R., Woel, I., Bowler, W. A. et al. (1994). Tumor necrosis factor, interleukin-2, and interferon-gamma in adult varicella. J. Med. Virol., 43, 69-71.
78. Warren, M. K., Rose, W. L., Cone, J. L., Rice, W. G., and Turpin, J. A. (1997). Differential infection of CD34+ cell derived dendritic cells and monocytes with lymphocyte tropic and monocyte tropic HIV strains. J. Immunol., 158, 5035-5042.
79. Webster, A., Grint, P., Brenner, M.K. et al. (1989). Titration of IgG antibodies against varicella zoster virus before bone marrow transplantation is not predictive of future zoster. J. Med. Virol., 27 117.
80. Wiertz, E. J., Jones, T. R., Sun, L., Bogyo, M., Geuze, H. J., and Ploegh, H. L. (1996). The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell, 84, 769-779.
81. York, I. A., Roop, C., Andrews, D. W., Riddell, S. R., Graham, F. L., and Johnson, D. C. (1994). A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell, 77, 525-535.
82. Young, J. W. and Steinman, R. M. (1990). Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells. J. Exp. Med., 171, 1315-1332.
83. Young, J. W., Koulova, L., Soergel, S. A., Clark, E. A., Steinman, R. M., and Dupont, B. (1992). The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro. J. Clin. Invest., 90, 229-237.
84. Zarling, J. M., Moran, P. A., Burke, R. L., Pachl, C., Berman, P. W., and Lasky, L. A. (1986). Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activationbyclonedglycoproteinsgBandgD. J. Immunol., 136, 4669-4673.
85. Zhang, Y., Cosyns, M., Levin, M. J., and Hayward, A. R. (1994). Cytokine production in varicella zoster virus-stimulated lim-iting dilution lymphocyte cultures. Clin. Exp. Immunol., 98, 128-133.
86. Zhou, L. J., Schwarting, R., Smith, H. M., and Tedder, T. F. (1992). A novel cell-surface molecule expressed by human interdigitat-ing reticulum cells, Langerhans cells, and activated lympho-cytes is a new member of the Ig superfamily. J. Immunol., 149, 735-742.
87. Zhou, L. J. and Tedder, T. F. (1995). Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol., 154, 3821-3835.